MINI FUTURE OPTIONSSCHEIN PUT - FRESENIUS MEDICAL CARE Share Price

Certificat

DE000DJ4WG77

Delayed Deutsche Boerse AG 11:34:24 11/07/2024 pm IST
1.2 EUR -0.83% Intraday chart for MINI FUTURE OPTIONSSCHEIN PUT - FRESENIUS MEDICAL CARE
Current month-4.72%
1 month+34.44%
Date Price Change
11/24/11 1.2 -0.83%
10/24/10 1.21 -3.97%
09/24/09 1.26 +0.80%
08/24/08 1.25 +2.46%
05/24/05 1.22 -2.40%

Delayed Quote Deutsche Boerse AG

Last update July 11, 2024 at 11:34 pm IST

More quotes

Static data

Product typeKnock-Out with Stop Loss
Buy / SellPUT
Underlying FRESENIUS MEDICAL CARE AG
Issuer DZ BANK
WKN DJ4WG7
ISINDE000DJ4WG77
Date issued 16/08/2023
Strike 48.37
Maturity Unlimited
Parity 10 : 1
Emission price 0.418
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 1.86
Lowest since issue 0.39
Spread 0.02
Spread %1.64%

Company Profile

Fresenius Medical Care AG, formerly Fresenius Medical Care AG & Co. KGaA is a Germany-based Company, which is a kidney dialysis institute. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company also develops and manufactures a wide variety of health care products, which includes dialysis and non-dialysis products. Its dialysis products include hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. The Company supplies dialysis clinics it owns, operates or manages with a broad range of products, and sells dialysis products to other dialysis service providers.
Sector
-
More about the company

Ratings for Fresenius Medical Care AG

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Fresenius Medical Care AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
36.22 EUR
Average target price
39.97 EUR
Spread / Average Target
+10.36%
Consensus